Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-23

FDA Approved: DALFAMPRIDINE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved the original application for dalfampridine as a generic product manufactured by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dalfampridine (dalfampridine)

Snippet

ORIG AP for DALFAMPRIDINE (DALFAMPRIDINE)